Thus, our identification of AD/G9a-coupregulated, MS1262-suppressed expression of GMFB protein validated our discovery that G9a-translational mechanism outperforms G9a-suppressed transcription in defining the proteopathologic nature of AD pathogenesis. This evidence concerns the gene GMFB and Alzheimer disease.